Option Care Health Leaders: ‘We Learned A Lot’ From Failed Amedisys Acquisition

Option Care Health (NYSE: OPCH), the home-based and alternate site infusion services provider, had one heck of a 2023. But, about six months removed from its failed attempt to acquire Amedisys Inc. (Nasdaq: AMED), it still remains a home-based care provider worth paying attention to. On Tuesday at the J.P. Morgan Healthcare Conference, the company’s […]

Top Home Care Trends For 2024

The rising costs of home care were a trend in 2022 and 2023. They will remain one in 2024, and could finally come to a head. That’s only one trend, of many, that will impact home care providers in the new year. But it alone will also lead to other trends, such as increased M&A, […]

The Top 10 Home Health Care News Stories Of 2023

In the first year that truly felt “post-COVID,” home-based care providers did not see a shortage of challenges. Instead, in 2023, home health providers saw another year defined by payment struggles, with both the Centers for Medicare & Medicaid Services (CMS) and Medicare Advantage (MA) plans. Home care providers, meanwhile, were still grappling with high […]

The Home-Based Care Executive Quotes That Struck A Chord In 2023

To find the most memorable home-based care executive quotes in 2023, Home Health Care News employed a strategy that is part art, part science. Ultimately, the quotes chosen resonated the most with HHCN’s staff and readers. They were prescient, controversial, telling and highly relevant to provider struggles and opportunities. They touched on the Centers for […]

For Home Health Providers, Clinician Scheduling Stands Out As Turnover Culprit

Staffing is a universal pain point for home health providers. Specifically, that pain point is about recruiting and retaining talent, and most provider leaders argue that retention is the area their organizations need to focus on. Break retention down even further, though, and you find a main culprit for turnover: scheduling. “[Scheduling] is one of […]

Lawmakers Elizabeth Warren, Pramila Jayapal Urge DOJ To Further Scrutinize Optum-Amedisys Deal

Lawmakers are hoping to direct further scrutiny toward UnitedHealth Group’s (NYSE: UNH) pending deal of the home health giant Amedisys Inc. (Nasdaq: AMED). Specifically, Sen. Elizabeth Warren (D-Mass.) and U.S. Rep. Pramila Jayapal (D-Wash.) have asked antitrust regulators to take a closer look. “We urge DOJ and FTC to closely scrutinize UnitedHealth’s proposed acquisition of […]